Published in Pharm Res on August 01, 2004
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials (2010) 1.14
Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design. Daru (2010) 1.11
Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomedicine (2011) 0.95
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB J (2010) 0.94
Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech (2010) 0.92
A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett (2012) 0.89
Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int J Nanomedicine (2011) 0.88
Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. Acta Biomater (2013) 0.87
Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells. J Drug Target (2010) 0.87
Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy. Int J Nanomedicine (2014) 0.86
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. J Transplant (2012) 0.86
Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV/AIDS microbicide in vitro. AAPS J (2013) 0.85
Critical evaluation of biodegradable polymers used in nanodrugs. Int J Nanomedicine (2013) 0.84
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. PLoS One (2011) 0.83
Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants. Vet Res Commun (2009) 0.83
Lymphatic biodistribution of polylactide nanoparticles. Mol Imaging (2010) 0.83
Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1). AAPS PharmSciTech (2015) 0.82
Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging. Small (2016) 0.82
Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. Daru (2013) 0.82
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. PLoS One (2013) 0.81
Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. Int J Pharm (2013) 0.81
Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech (2009) 0.79
Microparticles prepared from sulfenamide-based polymers. J Microencapsul (2013) 0.78
Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2). AAPS PharmSciTech (2016) 0.78
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy. Cancer Nanotechnol (2012) 0.77
PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release. Int J Mol Sci (2014) 0.77
Development of phenylboronic acid-functionalized nanoparticles for emodin delivery. J Mater Chem B Mater Biol Med (2015) 0.77
Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Drug Des Devel Ther (2015) 0.77
Food antimicrobials nanocarriers. ScientificWorldJournal (2014) 0.76
Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics. Int J Oncol (2013) 0.76
Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration. Int J Nanomedicine (2016) 0.76
Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med (2015) 0.75
Preparation and Characterization of Pistacia khinjuk Gum Nanoparticles Using Response Surface Method: Evaluation of Its Anti-Bacterial Performance and Cytotoxicity. Adv Pharm Bull (2017) 0.75
Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems. Kona (2016) 0.75
Detection of Cronobacter sakazakii in powdered infant formula using an immunoliposome-based immunomagnetic concentration and separation assay. Sci Rep (2016) 0.75
Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles. Int J Mol Sci (2016) 0.75
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS PharmSciTech (2006) 0.75
In vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapies. Int J Environ Res Public Health (2014) 0.75
Nanoencapsulation for drug delivery. EXCLI J (2014) 0.75
Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharm J (2014) 0.75
Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev (2006) 2.53
State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B (2002) 2.19
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci (2005) 1.77
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev (2008) 1.27
Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci (2004) 1.26
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech (2005) 1.22
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm (2002) 1.21
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm (2005) 1.17
Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke (2007) 1.16
Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst (2005) 1.16
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm (2003) 1.13
Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol (2010) 1.13
Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. Eur J Pharm Biopharm (2009) 1.13
Theranostic applications of nanoparticles in cancer. Drug Discov Today (2012) 1.12
Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials (2009) 1.06
Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem (2006) 1.04
Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res (2004) 1.01
Silica-based nanoparticles for biomedical applications. Drug Discov Today (2012) 1.01
A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm (2005) 1.01
Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci (2003) 1.00
Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm (2006) 0.96
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials (2009) 0.96
Dirhenium decacarbonyl-loaded PLLA nanoparticles: influence of neutron irradiation and preliminary in vivo administration by the TMT technique. Int J Pharm (2007) 0.93
Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol (2003) 0.92
Mechanism of nanocapsules formation by the emulsion-diffusion process. J Colloid Interface Sci (2007) 0.92
Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release (2009) 0.90
Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin. Int J Pharm (2005) 0.90
Freeze-drying of nanocapsules: impact of annealing on the drying process. Int J Pharm (2006) 0.89
Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur J Dermatol (2009) 0.89
Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opin Drug Deliv (2012) 0.89
Assessment methods of inhaled aerosols: technical aspects and applications. Expert Opin Drug Deliv (2009) 0.88
Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. J Colloid Interface Sci (2006) 0.88
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. Eur J Pharm Biopharm (2004) 0.88
In vitro sonothrombolysis of human blood clots with BR38 microbubbles. Ultrasound Med Biol (2012) 0.87
Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release (2005) 0.87
Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm (2003) 0.87
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res (2010) 0.87
In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. Thromb Res (2009) 0.86
Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol (2005) 0.86
Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int J Pharm (2007) 0.86
Preparation of vancomycin microparticles: importance of preparation parameters. Int J Pharm (2006) 0.85
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci (2005) 0.85
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther (2009) 0.85
Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery. J Microencapsul (2008) 0.85
Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci (2005) 0.84
Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging. Biomaterials (2012) 0.84
Polymer encapsulation of inorganic nanoparticles for biomedical applications. Int J Pharm (2013) 0.83
Molecular recognition by Kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres. Bioorg Med Chem (2002) 0.83
Cell interaction studies of PLA-MePEG nanoparticles. Int J Pharm (2003) 0.83
Study of the effect of formulation parameters/variables to control the nanoencapsulation of hydrophilic drug via double emulsion technique. J Biomed Nanotechnol (2011) 0.82
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Int J Hyperthermia (2009) 0.81
pH-sensitive micelles for targeted drug delivery prepared using a novel membrane contactor method. ACS Appl Mater Interfaces (2013) 0.81
Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch. Chem Pharm Bull (Tokyo) (2002) 0.81
Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study. Eur J Pharm Biopharm (2011) 0.81
Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation. Pharm Res (2012) 0.81
Process induced transformations during tablet manufacturing: phase transition analysis of caffeine using DSC and low frequency micro-Raman spectroscopy. Int J Pharm (2011) 0.81
Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Eur J Pharm Sci (2006) 0.80
Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release. J Nanosci Nanotechnol (2011) 0.80
Engineered nanoparticulate drug delivery systems: the next frontier for oral administration? AAPS J (2012) 0.80
Cardiovascular effects of selected water-miscible solvents for pharmaceutical injections and embolization materials: a comparative hemodynamic study using a sheep model. PDA J Pharm Sci Technol (2007) 0.79
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm (2003) 0.79
New oil-in-water magnetic emulsion as contrast agent for in vivo magnetic resonance imaging (MRI). J Biomed Nanotechnol (2013) 0.79
Synthesis and characterisation of novel nanospheres made from amphiphilic perfluoroalkylthio-beta-cyclodextrins. Eur J Pharm Biopharm (2005) 0.79
Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. I. Pulse-field-gradient spin-echo NMR study of sodium salicylate diffusivity in swollen hydrogels with respect to polymer matrix physical structure. J Control Release (2008) 0.79
Nucleoside analogue delivery systems in cancer therapy. Expert Opin Drug Deliv (2007) 0.79
A new method for liposome preparation using a membrane contactor. J Liposome Res (2010) 0.78
Liposome and niosome preparation using a membrane contactor for scale-up. Colloids Surf B Biointerfaces (2012) 0.78
Intrinsically radiopaque iodine-containing polyvinyl alcohol as a liquid embolic agent: evaluation in experimental wide-necked aneurysms. J Neurosurg (2006) 0.78
Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumoral therapy. Eur J Pharm Biopharm (2007) 0.78
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles. J Pharm Sci (2005) 0.78
Holmium-loaded PLLA nanoparticles for intratumoral radiotherapy via the TMT technique: preparation, characterization, and stability evaluation after neutron irradiation. Drug Dev Ind Pharm (2008) 0.78
Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics. Int J Pharm (2006) 0.78
Standard measurement of clot-bound thrombin by using a chromogenic substrate for thrombin. Thromb Res (2004) 0.78
Highly temperature responsive core-shell magnetic particles: synthesis, characterization and colloidal properties. J Colloid Interface Sci (2011) 0.78
Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents. Drug Dev Ind Pharm (2010) 0.78
Determination of prothombinase activation after adding human purified prothrombin to human clot: comparison of hirudin, an activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation. Blood Coagul Fibrinolysis (2005) 0.78
Usefulness of controlled release of growth factors in investigating the early events of dentin-pulp regeneration. J Endod (2013) 0.77
Iodinated nano-emulsions as contrast agents for preclinical X-ray imaging: Impact of the free surfactants on the pharmacokinetics. Eur J Pharm Biopharm (2012) 0.77
Ultrasound contrast agents for brain perfusion imaging and ischemic stroke therapy. J Neuroimaging (2005) 0.77
Essential oils encapsulated in liposomes: a review. J Liposome Res (2013) 0.76
Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages. Int J Pharm (2012) 0.76
Controlled release carriers of growth factors FGF-2 and TGFbeta1: synthesis, characterization and kinetic modelling. J Biomed Nanotechnol (2010) 0.76
Nanoparticles via nanoprecipitation process. Recent Pat Drug Deliv Formul (2012) 0.76
Paclitaxel-loaded microparticles for intratumoral administration via the TMT technique: preparation, characterization, and preliminary antitumoral evaluation. Drug Dev Ind Pharm (2008) 0.76
Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs. Pharm Res (2007) 0.76
The impact of the salting-out technique on the preparation of colloidal particulate systems for pharmaceutical applications. Recent Pat Drug Deliv Formul (2012) 0.76
Preparation, characterization and in vitro evaluation of a new nucleotide analogue prodrug cyclodextrin inclusion complexes. J Nanosci Nanotechnol (2009) 0.76
Synthesis and characterisation of sulfated amphiphilic alpha-, beta- and gamma-cyclodextrins: application to the complexation of acyclovir. Carbohydr Res (2003) 0.75
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS PharmSciTech (2006) 0.75
Poly(ethylene glycol)-poly(ε-caprolactone) iodinated nanocapsules as contrast agents for X-ray imaging. Pharm Res (2013) 0.75